Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Marinus Pharmaceuticals (MRNS) News Today

Marinus Pharmaceuticals logo

MRNS Latest News

Marinus (MRNS) Gets a Hold from Truist Financial
Marinus (MRNS) Initiated with a Buy at Cantor Fitzgerald
About Marinus Pharmaceuticals
Marinus Pharmaceuticals price target lowered to $1 from $3 at RBC Capital
Marinus Pharmaceuticals downgraded to Market Perform at JMP Securities
Marinus Pharmaceuticals downgraded to Hold from Buy at Jefferies
Marinus Pharmaceuticals price target lowered to $3 from $23 at EF Hutton
balancing risk vs reward
3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity (MRNS)
Check out these three micro-cap stocks that show big-time potential upside, but also pose face large obstacles to achieving success.
Scientists working together in the medical laboratory, microscope in the foreground
Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Marinus is an under $2 biotech stock with Wall Street analysts price targets ranging from $2 to $13. Its upcoming trial results have big implications.
Southwest Airlines raises third-quarter revenue forecast
Get Marinus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRNS and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MRNS Media Mentions By Week

MRNS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRNS
News Sentiment

0.00

0.72

Average
Medical
News Sentiment

MRNS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRNS Articles
This Week

0

1

MRNS Articles
Average Week

Get the Latest News and Ratings for MRNS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Marinus Pharmaceuticals and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:MRNS) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners